Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial

INTRODUCTION: The optimal duration of antibiotic therapy for community-acquired pneumonia (CAP) is unsettled. Short-course therapy has proved successful in clinical trials but is not yet implemented in everyday clinical practice. Validation of results from randomised controlled trials is crucial to...

Descripción completa

Detalles Bibliográficos
Autores principales: Israelsen, Simone Bastrup, Tingsgård, Sandra, Thorlacius-Ussing, Louise, Knudsen, Andreas, Lindegaard, Birgitte, Johansen, Isik S, Mygind, Lone Hagens, Ravn, Pernille, Benfield, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364160/
https://www.ncbi.nlm.nih.gov/pubmed/37479519
http://dx.doi.org/10.1136/bmjopen-2022-069013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364160/
https://www.ncbi.nlm.nih.gov/pubmed/37479519
http://dx.doi.org/10.1136/bmjopen-2022-069013

Ejemplares similares